Clinical trial Recruiting at 1 site Interventional Ages 14 to 65

Investigating non-invasive brain stimulation for drug-resistant epilepsy

Official title: Evaluating Modulation Effects of Temporal Interference Using SEEG

Run by Xuanwu Hospital, Beijing · NCT06663969 · Data updated 2026-11-12

This study is testing a new non-invasive brain stimulation method to see if it can help people aged 14-60 with epilepsy that doesn't respond to medication.

Quick facts

Study typeInterventional
Ages14 Years to 65 Years
SexAll
Enrollment20 (estimated)
SponsorXuanwu Hospital, Beijing
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedNovember 4, 2024
Main results expectedSeptember 2025
Study endsOctober 2025
Registry record updatedFebruary 5, 2025
Trial IDNCT06663969 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 14-60 with a clinical diagnosis of drug-resistant epilepsy who have undergone implantation of stereotactic electrodes.

Probably not a fit

Patients with severe systemic diseases or complications at the electrode site may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective study explores the effects of temporal interference (TI) on deep brain stimulation in patients aged 14-60 with drug-resistant epilepsy. By utilizing stereoelectroencephalography (SEEG), the study aims to analyze the electrophysiological mechanisms of TI, which generates focused stimulation in targeted brain areas without invasive procedures. Clinical, imaging, and electrophysiological data will be collected and analyzed to enhance understanding of TI's impact on brain function and its potential as a treatment alternative.

Why it matters

Potential benefit: If successful, this approach could provide a non-invasive treatment option for patients with drug-resistant epilepsy.

How similar studies have gone: While temporal interference is a novel approach, similar studies in non-invasive brain stimulation have shown promising results, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical diagnosis of drug-resistant epilepsy;
* No severe systemic diseases;
* Implantation of stereotactic electrodes;
* Agreement to participate in this study and signs the informed consent form.

Exclusion Criteria:

* Hematoma at the scalp electrode site or fluid accumulation under the electrode after intracranial electrode placement.

Where it's running

  • Xuanwu Hospital,Capital Medical University
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.